Thrombomodulin activity of fat-derived microvascular endothelial cells seeded on expanded polytetrafluorethylene.
Lining the luminal surface of prosthetic vascular grafts with endothelial cells (cell seeding) will lower its thrombogenicity. Commonly used macrovascular human adult endothelial cells (HAEC) require in vitro cultivation before large enough numbers are obtained to cover grafts confluently. Fat-derived microvascular endothelial cells (MVEC) prove to be a good alternative as they can be harvested in much larger numbers while showing similar antithrombotic and fibrinolytic characteristics. An important anticoagulant function of macrovascular endothelial cells is due to the activity of thrombomodulin (TM) on their surface. In this study, the presence and functional activity of TM on fat-derived microvascular cells used in cell seeding was investigated. The expression and localization of TM on MVEC was studied using immunohistochemistry. Functional activity of TM on MVEC was measured by the generation of activated protein C (APC) and was compared to human umbilical vein endothelial cells (HUVEC). TM activity was studied in MVEC seeded on expanded polytetrafluorethylene (ePTFE) vascular prostheses and compared to blank prostheses. We found that TM was expressed on the surface of MVEC, both in vivo and vitro. TM-dependent generation of APC differed significantly between MVEC and HUVEC (3.98 +/- 1.2 vs. 3.0 +/- 0.7 nM, respectively). After seeding MVEC on vascular prostheses, TM activity did not change. APC generation was significantly higher on MVEC-seeded vascular grafts compared to blank grafts (4.0 +/- 0.7 vs. 1.7 +/- 0.5 nM, respectively). We conclude that TM is present and highly active on cultured MVEC. When seeded on ePTFE, MVEC retain the possibility to inhibit thrombin coagulant activity and to activate protein C. Therefore, since MVEC are readily available, the anticoagulant properties demonstrated here indicate that this cell type is suitable for cell seeding of vascular prostheses.
Hedeman Joosten
P P
PP
Departments of Surgery and Hematology, University Hospital Utrecht, The Netherlands.
Verhagen
H J
HJ
Heijnen-Snyder
G J
GJ
Sixma
J J
JJ
de Groot
P G
PG
Eikelboom
B C
BC
Elisen
M G
MG
D000273:Adipose Tissue / Q000098:blood supply*; D001777:Blood Coagulation / Q000187:drug effects / Q000502:physiology; D001807:Blood Vessel Prosthesis; D003584:Cytological Techniques; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism* / Q000502:physiology; D005337:Fibrin / Q000096:biosynthesis; D006801:Humans; D008833:Microcirculation / Q000502:physiology; D011138:Polytetrafluoroethylene; D011486:Protein C / Q000502:physiology; D013917:Thrombin / Q000494:pharmacology; D018180:Thrombomodulin / Q000378:metabolism* / Q000502:physiology; D013925:Thromboplastin / Q000502:physiology; D014471:Umbilical Veins / Q000166:cytology / Q000378:metabolism
D011486:Protein C; D018180:Thrombomodulin; D005337:Fibrin; D011138:Polytetrafluoroethylene; D013925:Thromboplastin; D013917:Thrombin